Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
domingo, agosto 23
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Surgery Partners Inc
SGRY
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$14.52
0.58
4.16%
al cierre: Aug 21, 5:00 PM EST
$14.53
0.01
0.07%
After hour: Aug 21, 6:22 PM EST
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Surgery Partners Financials
Surgery Partners (SGRY) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Surgery Partners Q2 Adj. EPS $0.10 Beats $0.06 Estimate, Sales $848.900M Beat $830.366M Estimate
Surgery Partners (NASDAQ:SGRY) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.06 by 66.67 percent. This is a 41.18 percent decrease over earnings of $0.17 per share from
Benzinga Newsdesk
PRO
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est
Surgery Partners (NASDAQ:SGRY) affirms FY2026 sales outlook from $3.350 billion-$3.450 billion to $3.350 billion-$3.450 billion vs $3.408 billion estimate.
Benzinga Newsdesk
Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth
Surgery Partners rises after agreeing to sell Idaho Falls hospital stakes for $795 million while reaffirming its 2026 outlook
Vandana Singh
PRO
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est
Surgery Partners (NASDAQ:SGRY) affirms FY2026 sales outlook from $3.350 billion-$3.450 billion to $3.350 billion-$3.450 billion vs $3.408 billion estimate.
Benzinga Newsdesk
PRO
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.411B Est
2026 GuidanceFull year 2026 revenue guidance reaffirmed to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million
Benzinga Newsdesk
PRO
Surgery Partners Q1 Adj. EPS $(0.03) Beats $(0.12) Estimate, Sales $810.900M Beat $797.892M Estimate
Surgery Partners (NASDAQ:SGRY) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.12) by 75 percent. This is a 175 percent decrease over earnings of $0.04 per share from the
Benzinga Newsdesk
Privacy Manager